Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00023742
DRKS00023742
Recruiting
Not Applicable

COVIDOM: Longterm morbidity of SARS-CoV-2 infection and COVID-19 disease – consequences for health status and quality of life - NAPKON - POP (National Pandemic Cohort Network - Population Based Platform)

Forschungsnetzwerk der Universitätsmedizin zu COVID-19 (Netzwerk Universitätsmedizin, NUM), Koordinierungsstelle Charité Berlin0 sites3,500 target enrollmentDecember 10, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCOVID19SARS-CoV-2 infection

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID19SARS-CoV-2 infection
Sponsor
Forschungsnetzwerk der Universitätsmedizin zu COVID-19 (Netzwerk Universitätsmedizin, NUM), Koordinierungsstelle Charité Berlin
Enrollment
3500
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 10, 2020
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Forschungsnetzwerk der Universitätsmedizin zu COVID-19 (Netzwerk Universitätsmedizin, NUM), Koordinierungsstelle Charité Berlin

Eligibility Criteria

Inclusion Criteria

  • •PCR\-confirmed SARS\-CoV\-2 infection, living in one of the target areas, age at least 18 years,
  • •written informed consent.

Exclusion Criteria

  • •Acute SARS\-CoV\-2 infection or reinfection

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Health Status and Quality of LifeCOVID-19
NCT04679584University Hospital Schleswig-Holstein2,000
Completed
Not Applicable
Long Term Impact of COVID-19Long COVID-19Post-COVID-19 SyndromeCOVID-19
NCT05813574Medisch Spectrum Twente835
Completed
Not Applicable
ongterm outcome of patients with COVID-19 associated akut respiratory distress syndrome (cARDS)COVID-19 and Follow-upLongCOVID DiseaseJ80.0
DRKS00027856niversitätsklinikum Carl Gustav Carus184
Active, not recruiting
Phase 1
ONGITUDINAL FOLLOW-UP OF SARS-COV-2 (COVID-19) IMMUNITY IN IMMUNOCOMPROMISED POPULATIONS IN BELGIUM (COVICO)A non-commercial multicenter academic prospective cohort study during 2023-2026Healthy persons and immunocompromised patients (nursing home residents, dialysis patients and kidney- and lung transplant patients) from age 18 till age 105Therapeutic area: Body processes [G] - Immune system processes [G12]
EUCTR2022-002531-56-BESciensano360
Completed
Not Applicable
Mid- to longterm outcome after severe COVID-19 associated respiratory failure with Extracorporeal Membrane Oxygenation (ECMO) therapyCOVID-19-related severe hypoxemic respiratory failure
DRKS00026752Herz- u. Diabeteszentrum NRW, Klinik für Thorax- und Kardiovaskularchirurgie60